Serum Asprosin, Metabolic Syndrome, and Cardiometabolic Risk in Rheumatoid Arthritis
Serum Asprosin, Metabolic Syndrome, and Cardiometabolic Risk in Rheumatoid Arthritis
Not yet recruiting · NCT07793747 · Registry updated 2026-08-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Serum Asprosin, Metabolic Syndrome, and Cardiometabolic Risk in Rheumatoid Arthritis | Arachnodactyly, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Insulin Resistance, Limb Deformities, Congenital, Musculoskeletal Abnormalities, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, glucose metabolism disease, hyperinsulinism, immune system disorder, metabolic disease, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Not yet recruiting | Not stated | 2026-08-31 | NCT07793747 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Assiut University | 1477 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||